Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
CAMP4 Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Study of CMP-CPS-001, a Potential First-in-Class Therapeutic for Urea Cycle Disorders
Read Article
News
2024
2023
Archive
Search news articles
October 30, 2019
New RarePlex® Developer Kits for CTC Characterization Provide Researchers Flexibility in Independent CTC Assay Development
October 29, 2019
Scientist.com Expands its Award-Winning Solution – COMPLi® – to Ensure Ethical Treatment of Animals During Scientific Research
October 25, 2019
Homology Medicines Presents Preclinical Data from its Investigational PKU Gene Editing Program, Demonstrating Phenotypic Correction and Molecular Confirmation of Editing Precision
October 25, 2019
Cabaletta Bio Announces Pricing of Initial Public Offering
October 24, 2019
Akouos Appoints Rabia Gurses Ozden, MD as Chief Development Officer
October 23, 2019
Arvinas Presents a Platform Update, Including Initial Data from the First Two Clinical Trials of PROTAC® Targeted Protein Degraders
October 18, 2019
Bird Rock Bio Announces Successful Completion of Phase 1B Safety Study and Readiness for Phase 2B Study of Nimacimab in Patients with Diabetic Kidney Disease
October 9, 2019
IDEAYA Announces First Patient Dosing of IDE196 for Solid Tumors Outside of Uveal Melanoma and a Collaboration with Foundation Medicine in Support of its Tumor-Agnostic GNAQ/11 Basket Trial
October 7, 2019
Aprea Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 7, 2019
Audentes Therapeutics Presents New Positive Data From ASPIRO, the Clinical Trial Evaluating AT132 in Patients with X-Linked Myotubular Myopathy (XLMTM), at the 24th International Annual Congress of the World Muscle Society
« Previous Page
1
…
61
62
63
64
65
…
118
Next Page »